Stock Analiz

Cel Sci Corp. CVM

Biotechnology: Biological Products (No Diagnostic Substances) · IPO 1997 · data as of November 13, 2026

$1.28Market cap $23M
Open the interactive analysis →

Cel Sci Corp. (CVM) is a healthcare company listed in the US with a market value of about $23M.

Its overall Stock Analiz score is 0.2 out of 5 (weak). The strongest part is financial health (1/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -104%.

About Cel Sci

Cel Sci is listed in the US and classified in biotechnology: biological products (no diagnostic substances), IPO year 1997. It was profitable in 0 of the last 10 years in our data. Its share count rose by 182% over three years (dilution for shareholders).

Score: 0.2 / 5

Value0/5
Future growth0/5
Track record0/5
Financial health1/5
Shareholder returns0/5

Checks passed

  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S—
P/B2.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-74.4%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)—
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)—
ROIC (5-yr avg.)-103.6%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal year2025202420232022202120202019201820172016
Revenue——————————
Net income-$25M-$27M-$32M-$37M-$36M-$30M-$22M-$32M-$14M-$12M
Free cash flow-$17M-$19M-$23M-$19M-$28M-$18M-$16M-$13M-$14M-$23M
EPS (diluted)$-6.27$-15.31$-21.90$-26.10$-27.00$-24.60$-21.30$-56.10$-57.30$-71.10
Net margin——————————
ROIC-77.3%-143.4%-165.1%-83.3%-48.8%-109.4%-310.8%-1446500.0%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Cel Sci pay a dividend?

Not currently.

Is Cel Sci a good stock to buy?

We do not give buy or sell advice. Cel Sci scores 0.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.